| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |